Faculty profile

David Safronetz

ResearcherUniversity of Manitoba

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.

David Safronetz

Researcher

Health Sciences

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
34 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

132

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Animal Models Of Disease Lassa Fever Lassa Virus Preclinical Development Vaccine

Latest papers

Searching for immune correlates in Lassa vaccine development - workshop report.
NPJ vaccines · 2026
Waning humoral immunity following monkeypox virus infection and vaccination, Canada, 2020 to 2023.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026 · senior author
Genomic characterization of Lao Mobatvirus strains reveals host-associated clustering in Southeast Asian bats.
The Journal of general virology · 2026

All 99 publications

Latest funding

Empowering Large-Scale Infectious Disease Research and Mobilizing Knowledge: The Serology and Diagnostics High-Throughput Platform as Critical Research Infrastructure for Pandemic Preparedness, Surveillance, and Response in Canada
CIHR · 2025 · Co-investigator
$2,999,998
Non-human primate depletion models for the study of Lassa virus pathogenesis and correlates of protection associated with Lassa fever vaccines.
CIHR · 2021 · Nominated PI
$200,000

All 2 grants and awards

99 publications.

Searching for immune correlates in Lassa vaccine development - workshop report.

Brasel T, Brangel P, Adetifa I, Baize S, Benkeser D, Bertoletti A, Bukreyev A, Charlton S, Cramer J, Cross RW, Davenport MP, Emperador D, Formenty P, Follmann D, Garry RF, Gilbert PB, Gilbert SC, Gollihar JD, Grassly NC, Gruber M, Gupta SB, Günther S, Hacker A, Hoath C, Holbrook MR, Killip M, King D, Mandi H, Munster VJ, Mukandavire C, Oestereich L, Okogbenin S, Oloo P, Paessler S, Plotkin S, Richert L, Safronetz D, Saphire EO, Sette A, Shurtleff A, Granerod J, Wohl D, Zaric M, Ramsauer K, Dahlke C

NPJ vaccines2026

DOI: 10.1038/s41541-026-01452-6 PMID: 42071009

Waning humoral immunity following monkeypox virus infection and vaccination, Canada, 2020 to 2023.

Prévost J, Medina SJ, Márquez AC, Dimitrova K, Valadbeigy T, Cortez GAP, Narayan M, Carson WC, Townsend MB, Jassem AN, Safronetz D

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026Senior author

DOI: 10.2807/1560-7917.es.2026.31.14.2500479 PMID: 42141880

Genomic characterization of Lao Mobatvirus strains reveals host-associated clustering in Southeast Asian bats.

Vanhnollat C, Dimitrova K, Vachouaxiong L, Audet J, Somlor S, Medina SJ, Bounmany P, Lakeomany K, Vungkyly V, Wong G, Xayaphet V, Paphaphanh P, Theppangna W, Douangboubpha B, Vongphayloth K, Safronetz D, Buchy P

The Journal of general virology2026

DOI: 10.1099/jgv.0.002333 PMID: 42714963

Pathogenicity and antiviral treatment of clade Ib Monkeypox virus infection in mice.

Prévost J, Tailor N, Soule G, Medina SJ, Tierney K, Azaransky K, Safronetz D

Antiviral research2026Senior author

DOI: 10.1016/j.antiviral.2026.106377 PMID: 41724269

Assessment of three antiviral compounds against Borealpox virus infection in a mouse model.

Prévost J, Tailor N, Sloan A, Fulton K, Medina SJ, Audet J, Soule G, Safronetz D

Emerging microbes & infections2026Senior author

DOI: 10.1080/22221751.2026.2623694 PMID: 41591827

Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase.

Sloan A, Gordon CJ, Prévost J, Audet J, Fulton K, Woolner E, Chang MH, Walker SM, Tchesnokov EP, Das K, Safronetz D, Götte M

NAR molecular medicine2026

DOI: 10.1093/narmme/ugaf041 PMID: 41509513

High genomic stability of Andes virus following successive passage in vivo in Syrian hamsters.

Warner BM, Prévost J, Tailor N, Deschambault Y, Sloan A, Allarie J, Klassen L, Frost K, Booth S, Audet J, Soule G, Safronetz D

Journal of virology2025Senior author

DOI: 10.1128/jvi.00512-25 PMID: 40704892

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques.

Prévost J, Tailor N, Soule G, Audet J, Deschambault Y, Vendramelli R, Prado-Smith J, Tierney K, Azaransky K, Kobasa D, Clancy CS, Feldmann H, Rosenke K, Safronetz D

JCI insight2025Senior author

DOI: 10.1172/jci.insight.199235 PMID: 40996813

Assessing the Potential of Sexual Transmission of Lassa Virus in a Natural Rodent Reservoir.

Prévost J, Tailor N, Soule G, Frost K, Azaransky K, Tierney K, Feldmann H, Booth S, Rosenke K, Safronetz D

The Journal of infectious diseases2025Senior author

DOI: 10.1093/infdis/jiaf314 PMID: 40581828

Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.

Zhang W, Prévost J, Sloan A, Tamming L, Pfeifle A, Gravel C, Thulasi Raman SN, Van Domselaar G, Johnston MJW, Wang L, Sauve S, Rosu-Myles M, Kobasa D, Tran A, Chen W, Zhang X, Safronetz D, Li X

Antiviral research2025

DOI: 10.1016/j.antiviral.2025.106284 PMID: 41015121

Something wrong or missing on this profile? Suggest a correction

David Safronetz

Research

Latest papers

Latest funding

Searching for immune correlates in Lassa vaccine development - workshop report.

Waning humoral immunity following monkeypox virus infection and vaccination, Canada, 2020 to 2023.

Genomic characterization of Lao Mobatvirus strains reveals host-associated clustering in Southeast Asian bats.

Pathogenicity and antiviral treatment of clade Ib Monkeypox virus infection in mice.

Assessment of three antiviral compounds against Borealpox virus infection in a mouse model.

Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase.

High genomic stability of Andes virus following successive passage in vivo in Syrian hamsters.

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques.

Assessing the Potential of Sexual Transmission of Lassa Virus in a Natural Rodent Reservoir.

Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.

Empowering Large-Scale Infectious Disease Research and Mobilizing Knowledge: The Serology and Diagnostics High-Throughput Platform as Critical Research Infrastructure for Pandemic Preparedness, Surveillance, and Response in Canada

Non-human primate depletion models for the study of Lassa virus pathogenesis and correlates of protection associated with Lassa fever vaccines.

Frequent collaborators

Darwyn Kobasa

Lisheng Wang

Stephanie Booth

Uladzimir Karniychuk

Volker Gerdts

Andrew Potter

Brian Cox

Leonardo Susta

Gary Kobinger

Ana Duggan

Ma Luo

Derek Stein

Kalyan Das

Brian Raught

Hugues Loemba

Ruey-Chyi Su

Darryl Falzarano

Anne-Claude Gingras

Laurence Pelletier

Guy Boivin

Xiao-Jian Yao

Samira Mubareka